Wei-Li Zhao

6PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 21, 2022
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.

Jing Quan Lim, Dachuan Huang, Jason Yongsheng Chan

|Dec 02, 2021
CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.

Chen-Xing Zhao, Zi-Xun Yan, Jing-Jing Wen

|Oct 24, 2020
Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma.

Mu-Chen Zhang, Ying Fang, Li Wang

|Mar 31, 2019
MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.

Zhong Zheng, Rui Sun, Hui-Jin Zhao

|Dec 06, 2018
Advances in multiple omics of natural-killer/T cell lymphoma.

Jie Xiong, Wei-Li Zhao

|Nov 08, 2017
Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients.

Qing Shi, Rong Shen, Chao-Fu Wang

Pageof 1

Frequent Collaborators

1 joint publications

Qing Shi

1 joint publications

Rong Shen

1 joint publications

Xing Fan

1 joint publications

Bin-Shen Ou-Yang